Trade Summary

4 days ago, Eckhardt Sue Gail, serving as Dir at EXELIXIS, INC. (EXEL), sold 9,812 shares at $50.14 per share, for a total transaction value of $491,973.68. Following this transaction, Eckhardt Sue Gail now holds 16,079 shares of EXEL.

This sale represents a 37.90% decrease in Eckhardt Sue Gail's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, June 1, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, June 3, 2026 at 6:51 PM ET, 2 days after the trade was made.

EXELIXIS, INC. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.